ABPI joined by 16 new members in 1H 2008
The Association of the British Pharmaceutical Industry has announced that, for the first half of 2008, 16 firms have joined its ranks. The new members include three pharmaceutical companies taking up full membership and 13 general affiliate members. Despite being a period of consolidation for some drugmakers and with the search for expenditure savings a priority for all, the increased numbers are seen as a vote of confidence for the UK's pharmaceutical trade association.
The ABPI's head of membership services, Jeremy Way, said: "there has been particular positive growth in the general affiliate membership category, proving that the ABPI is recognised as a world class trade association and respected by the wider business community."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze